Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.49 |
| ▸ | ALB | P02768 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | XDH | P47989 | 6/20 | 0.34 |
| ▸ | SLC22A12 | Q96S37 | 6/20 | 0.34 |
| ▸ | AR | P10275 | 3/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.33 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24910063 | 0.87 | TTR (0.53) | TTRALBMEN1KMT2AXDH | |
| SCHEMBL24910093 | 0.84 | MEN1 (0.50) | TTRALBMEN1KMT2AXDH | |
| SCHEMBL24909899 | 0.83 | MEN1 (0.45) | TTRALBMEN1KMT2APTGS2 | |
| SCHEMBL24909769 | 0.82 | TTR (0.50) | TTRALBMEN1KMT2AXDH | |
| SCHEMBL24910051 | 0.80 | MEN1 (0.45) | TTRALBMEN1KMT2APTGS2 | |
| SCHEMBL24909826 | 0.79 | TTR (0.62) | TTRALBMEN1KMT2APTGS1 | |
| SCHEMBL24910002 | 0.78 | MEN1 (0.46) | TTRALBMEN1KMT2APTGS2 | |
| SCHEMBL24909835 | 0.77 | MEN1 (0.51) | TTRALBMEN1KMT2A | |
| SCHEMBL24909767 | 0.77 | TTR (0.51) | TTRALBMEN1KMT2APTGS2 | |
| SCHEMBL24909706 | 0.76 | TTR (0.58) | TTRALBMEN1KMT2AXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230024283-A1 | HERBICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230024283-A1 | HERBICIDAL COMPOUNDS | DDT, CBR3, GLRX3 | TTR 4497/4885ALB 3928/4885MEN1 3221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.